Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 Aug;71(2):119–122. doi: 10.1136/adc.71.2.119

Cardiovascular abnormalities in end stage renal failure: the effect of anaemia or uraemia?

K P Morris 1, J R Skinner 1, S Hunter 1, M G Coulthard 1
PMCID: PMC1029940  PMID: 7944530

Abstract

Children with end stage renal failure and anaemia have an increased cardiac index and often gross ventricular hypertrophy. Correction of anaemia with recombinant human erythropoietin (r-HuEpo) for less than six months results in a reduction in the cardiac index without a significant reduction in left ventricular hypertrophy. Seven children receiving dialysis (group 1) were studied to determine whether a reduction in left ventricular hypertrophy would occur after a 12 month period of r-HuEpo. A decrease in the cardiac index was seen by six months, and a significant reduction in left ventricular mass index and cardiothoracic ratio was seen by 12 months. Successful renal transplantation also results in a reduction in the cardiac index and left ventricular hypertrophy, but the relative contributions of correction of anaemia and correction of biochemical disturbance is unknown because they usually improve simultaneously. To investigate this, six children (group 2) who already had a mean haemoglobin concentration of 107 g/l while receiving dialysis were followed up for 12 months after successful transplantation. They showed no significant change in haemoglobin concentration, but a dramatic improvement in biochemistry. There was no significant change in cardiovascular function. Anaemia is the more dominant influence on cardiovascular function in end stage renal failure.

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cannella G., La Canna G., Sandrini M., Gaggiotti M., Nordio G., Movilli E., Maiorca R. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients. Clin Nephrol. 1990 Dec;34(6):272–278. [PubMed] [Google Scholar]
  2. Hüting J., Alpert M. A. Course of left ventricular diastolic dysfunction in end-stage renal disease on long-term continuous ambulatory peritoneal dialysis. Clin Nephrol. 1993 Feb;39(2):81–87. [PubMed] [Google Scholar]
  3. Hüting J., Kramer W., Reitinger J., Kühn K., Schütterle G., Wizemann V. Abnormal diastolic left ventricular filling by pulsed Doppler echocardiography in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol. 1991 Jul;36(1):21–28. [PubMed] [Google Scholar]
  4. Lai K. N., Barnden L., Mathew T. H. Effect of renal transplantation on left ventricular function in hemodialysis patients. Clin Nephrol. 1982 Aug;18(2):74–78. [PubMed] [Google Scholar]
  5. Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561–1566. doi: 10.1056/NEJM199005313222203. [DOI] [PubMed] [Google Scholar]
  6. London G. M., Zins B., Pannier B., Naret C., Berthelot J. M., Jacquot C., Safar M., Drueke T. B. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int. 1989 Nov;36(5):878–882. doi: 10.1038/ki.1989.274. [DOI] [PubMed] [Google Scholar]
  7. Morris K. P., Skinner J. R., Hunter S., Coulthard M. G. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure. Arch Dis Child. 1993 May;68(5):644–648. doi: 10.1136/adc.68.5.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morris K. P., Skinner J. R., Wren C., Hunter S., Coulthard M. G. Cardiac abnormalities in end stage renal failure and anaemia. Arch Dis Child. 1993 May;68(5):637–643. doi: 10.1136/adc.68.5.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. O'Regan S., Douste-Blazy M. Y., Ducharme G., Fouron J. C., Davignon A. Renal transplantation and cardiac function in pediatric patients. Clin Nephrol. 1982 May;17(5):237–240. [PubMed] [Google Scholar]
  10. Parfrey P. S., Harnett J. D., Griffiths S. M., Taylor R., Hand J., King A., Barre P. E. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron. 1990;55(2):114–120. doi: 10.1159/000185937. [DOI] [PubMed] [Google Scholar]
  11. Pascual J., Teruel J. L., Moya J. L., Liaño F., Jiménez-Mena M., Ortuño J. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol. 1991 Jun;35(6):280–287. [PubMed] [Google Scholar]
  12. Tagawa H., Nagano M., Saito H., Umezu M., Yamakado M. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics. Clin Nephrol. 1991 Jan;35(1):35–38. [PubMed] [Google Scholar]
  13. Teruel J. L., Pascual J., Jiménez M., Liaño F., Rivera M., Martínez J., Moya J. L., Ortuño J. Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin. Nephron. 1991;58(2):135–137. doi: 10.1159/000186402. [DOI] [PubMed] [Google Scholar]
  14. Teruel J. L., Rodriguez Padial L., Quereda C., Yuste P., Marcen R., Ortuño J. Regression of left ventricular hypertrophy after renal transplantation. A prospective study. Transplantation. 1987 Feb;43(2):307–309. doi: 10.1097/00007890-198702000-00030. [DOI] [PubMed] [Google Scholar]
  15. Zehnder C., Zuber M., Sulzer M., Meyer B., Straumann E., Jenzer H. R., Blumberg A. Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients. Nephron. 1992;61(1):21–25. doi: 10.1159/000186829. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES